SOPHSOPHiA GENETICS SA
$7.30+75% 1Y
$7.30
$3.8952 weeks$8.90
Is the business good?
How good a business is SOPH?
SOPHiA GENETICS SA keeps −101% of every revenue dollar as operating profit, against 2.8% for the median Health Information Services name.
−101%
Operating margin · Health Information Services median 2.8% · 12 months to Q2 2025
- Share count, year on year
- +4.4%
Share count, year on year · shareholders own a smaller slice than a year ago
- R&D as % of revenue
- 52%
R&D as % of revenue
- Gross margin
- 67%
Gross margin
| Year | Operating margin |
|---|---|
| FY2020 | −132% |
| FY2021 | −177% |
| FY2022 | −185% |
| FY2023 | −120% |
| FY2024 | −102% |
| FY2025 | −92% |
Details›
- Gross margin12 months to Q2 2025
- 67%
- Operating margin12 months to Q2 2025
- −101%
- Net margin12 months to Q2 2025
- −101%
- R&D as % of revenue
- 52%
- Revenue, trailing twelve months
- $68M
- Net income, trailing twelve months
- −$69M
Margins, capital and share counts from the statements as filed with the SEC; cash conversion is operating cash flow over operating profit after tax.
Health Information Services
Ranks #13 of 20 by RyuScore